Invention Grant
- Patent Title: Compounds and compositions for inducing chondrogenesis
-
Application No.: US16448547Application Date: 2019-06-21
-
Publication No.: US10660881B2Publication Date: 2020-05-26
- Inventor: Ha-Soon Choi , James Paul Lajiness , Srinivasa Reddy Natala , Bao Nguyen , Hank Michael James Petrassi , Zhicheng Wang
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Genomics Institute of the Novartis Research Foundation
- Agent Emily T. Wu
- Main IPC: C07D493/08
- IPC: C07D493/08 ; A61K31/443 ; A61P19/02 ; A61K31/4245 ; A61K31/4155 ; A61K31/506 ; A61K31/34 ; A61K31/4439 ; A61K31/5377 ; A61K31/351 ; A61K31/4545 ; A61K31/4525 ; A61K31/497 ; A61K31/444 ; A61K45/06 ; C07D491/18 ; A61K31/416 ; A61K31/4433 ; A61L27/54 ; C12N5/077

Abstract:
The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds, and methods of using such compounds for treatment of joint damage or joint injury in a mammal, and for inducing differentiation of mesenchymal stem cells into chondrocytes.
Public/Granted literature
- US20190314348A1 COMPOUNDS AND COMPOSITIONS FOR INDUCING CHONDROGENESIS Public/Granted day:2019-10-17
Information query